Dyne Therapeutics
The Associate Director, Commercial Insights and Analytics at Dyne Therapeutics leads market insights to support commercial readiness for the company’s initial rare neuromuscular disease product launches. The role partners cross-functionally with marketing, market access, finance, supply, trade, and program teams to inform brand strategy and execution and reports to the Senior Director, Insights and Analytics. The position is based in Waltham, MA.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
Dyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for genetically driven neuromuscular diseases. Leveraging its proprietary FORCE™ platform, Dyne aims to address the root cause of disease and deliver functional improvement for people living with conditions such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD). The company advances a pipeline of therapeutics from discovery through clinical development with the mission of transforming the lives of patients with rare neuromuscular diseases.
Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)
2 days ago
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
3 days ago
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
22 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dyne Therapeutics.
150-patient Dyne trial focuses on myotonic dystrophy daily function
3 days ago
Director / Senior Director, Commercial Analytics & Insights
BridgeBio Pharma
Associate Director, Brand Analytics – Rare Disease (RD)
Sanofi
Director, Insights & Analytics
Beam Therapeutics
Manager, Brand Analytics & Insights, Rare Disease
Ipsen
Senior Director, Insights & Analytics - Rare Disease
Regeneron Pharmaceuticals
CD&A - Data Analytics Senior Manager, Rare Disease
Amgen